申请人:HOFFMANN LA ROCHE
公开号:WO2000058293A2
公开(公告)日:2000-10-05
The present invention relates to compounds of formula (I) wherein R?1, R2, R3 and R4¿ are as defined in claim 1 and pharmaceutically acceptable salts thereof. The compounds are glucokinase activators which increase insulin secretion in the treatment of type II diabetes.